- Home
- LRFC vs ECOR Comparison
LRFC vs ECOR Comparison
Compare LRFC & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRFC
- ECOR
- Stock Information
- Founded
- LRFC 2013
- ECOR 2005
- Country
- LRFC United States
- ECOR United States
- Employees
- LRFC N/A
- ECOR N/A
- Industry
- LRFC Finance: Consumer Services
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LRFC Finance
- ECOR Health Care
- Exchange
- LRFC Nasdaq
- ECOR Nasdaq
- Market Cap
- LRFC 47.6M
- ECOR 50.1M
- IPO Year
- LRFC 2013
- ECOR 2018
- Fundamental
- Price
- LRFC $17.05
- ECOR $5.36
- Analyst Decision
- LRFC
- ECOR Strong Buy
- Analyst Count
- LRFC 0
- ECOR 2
- Target Price
- LRFC N/A
- ECOR $25.50
- AVG Volume (30 Days)
- LRFC 9.2K
- ECOR 162.1K
- Earning Date
- LRFC 05-08-2025
- ECOR 05-07-2025
- Dividend Yield
- LRFC 8.45%
- ECOR N/A
- EPS Growth
- LRFC N/A
- ECOR N/A
- EPS
- LRFC N/A
- ECOR N/A
- Revenue
- LRFC $20,544,000.00
- ECOR $26,458,000.00
- Revenue This Year
- LRFC N/A
- ECOR $23.21
- Revenue Next Year
- LRFC N/A
- ECOR $44.10
- P/E Ratio
- LRFC N/A
- ECOR N/A
- Revenue Growth
- LRFC 3.11
- ECOR 41.54
- 52 Week Low
- LRFC $16.57
- ECOR $4.47
- 52 Week High
- LRFC $26.00
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- LRFC 33.20
- ECOR 45.95
- Support Level
- LRFC $17.60
- ECOR $4.77
- Resistance Level
- LRFC $18.04
- ECOR $5.49
- Average True Range (ATR)
- LRFC 0.43
- ECOR 0.42
- MACD
- LRFC 0.02
- ECOR 0.13
- Stochastic Oscillator
- LRFC 26.37
- ECOR 53.64
About LRFC Logan Ridge Finance Corporation
Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.